We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Donor Plasma Screened for Viral Antibodies

By LabMedica International staff writers
Posted on 02 May 2011
An enzyme immunoassay kit revealed that a proportion of blood donors in France have been exposed to the Toscana virus (TOSV). More...


The presence of immunoglobulin G (IgG) and IgM against TOSV in the plasma of the donors suggests a potential risk for transmitting the virus through blood transfusion or organ transplantation.

Scientists at the University of the Mediterranean, (Marseille, France), tested the plasma collected from 729 blood donors in seven French territorial divisions during the summer of 2007 for the presence of TOSV antibodies. A commercial enzyme immunoassay (EIA) kit was developed by using the recombinant nucleocapsid (N) protein of TOSV. This serologic test had been validated in a previous study that revealed high specificity and sensitivity.

The results showed that 84/729 (11.5%) plasma samples were positive for IgG against TOSV N protein. Twenty-four (3.3%) plasma samples were positive for IgM and five (0.7%) were positive for both IgG and IgM. To confirm the results, the IgG-positive samples were further subjected to Western blot (WB) analysis by using the TOSV isolate H/IMTSSA infected cell lysate. In 233 (32%) of the samples, protein of molecular mass compatible with that of the N protein was detected.

To detect TOSV ribonucleic acid (RNA), the investigators processed IgM-positive plasma samples by reverse transcription–polymerase chain reaction (RT-PCR). The finding of IgM is an indication of a recent exposure to the virus and hence its possible presence in blood. The RT-PCR did not detect any viral RNA in the samples. These negative results could indicate either cleared viremia or a low viral load, below the sensitivity limit of the test. TOSV prevalence in Corsica, an island in the Mediterranean Sea, was unexpectedly high. In this region, 10 of the 115 donors, (8.7%), of the population sampled showed an IgG- or IgM-positive response. In the other districts, the IgM seroprevalence did not exceed 4.4%.

The commercial enzyme immunoassay kit used is known as the EIA Enzywell Toscana virus IgG and IgM, and produced by DIESSE Diagnostica Senese S.p.A.; Siena, Italy).

Toscana virus is an arthropod-borne RNA virus (family Bunyaviridae and genus Phlebovirus) transmitted by phlebotomine sand flies in Mediterranean countries. TOSV causes acute meningitis and meningoencephalitis in patients. The study was published in May 2011, in the journal Emerging Infectious Diseases.

Related Links:
University of the Mediterranean
DIESSE Diagnostica Senese S.p.A



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.